Galenica to Acquire Relypsa for $32 per Share (RLYP)Thursday, July 21, 2016 · 11:35 am |
|
Relypsa: Company Releases Veltassa Launch Metrics for May (RLYP, $18.14, Buy)Thursday, June 16, 2016 · 10:13 am |
|
Relypsa: FDA Issuance of a CRL for ZS-9 is a Significant Positive (RLYP, Buy, $18.50)Friday, May 27, 2016 · 12:50 pm |
|
Relypsa: Comments on Possible Outcomes of ZS-9 PDUFA DateWednesday, May 25, 2016 · 3:14 pm |
|
Relypsa: Analyzing April Results of the Veltassa Launch (RLYP, Buy, $14.00)Tuesday, May 17, 2016 · 9:08 am |
|
Relypsa: Update Following 1Q, 2016 Conference Call (RLYP, Buy, $14.15)Friday, May 13, 2016 · 12:29 pm |
|
Relypsa: Analyzing March Results of the Veltassa Launch (RLYP, Buy, $17.60)Monday, April 18, 2016 · 2:27 pm |
|
Relypsa: Comments on Takeover RumorsThursday, April 7, 2016 · 5:19 pm |
|
Relypsa: It Is Early Days in the Launch of Veltassa but the Momentum Seems Quite Strong (RLYP, Buy, $13.46)Sunday, March 20, 2016 · 10:32 am |
|
Relypsa: An In-depth Analysis of Early Results of the Veltassa Launch (RLYP, Buy, $13.26)Tuesday, March 1, 2016 · 9:00 am |
|
Relypsa: New Buy Recommendation on Relypsa (RLYP, Buy, $14.98)Thursday, February 25, 2016 · 12:55 pm |
|
ZS Pharma: Astra Zeneca to Acquire ZS Pharma at $90 per Share-DARN (ZSPH, $90)Sunday, November 8, 2015 · 8:32 am |
|
Initiation Report on ZS Pharma (ZSPH, Buy, $40.97, Subscribers only)Saturday, April 25, 2015 · 8:03 am |
|
|
There are 13 reports on file. |
